Author:
Okutur Kerem,Demir Gokhan
Publisher
Springer International Publishing
Reference186 articles.
1. Lorusso V. Bevacizumab in the treatment of HER2-negative breast cancer. Biologics. 2008;2:813–21.
2. Bareschino MA, Schettino C, Colantuoni G, Rossi E, Rossi A, Maione P, et al. The role of antiangiogenetic agents in the treatment of breast cancer. Curr Med Chem. 2011;18:5022–32.
3. Azam F, Mehta S, Harris AL. Mechanisms of resistance to antiangiogenesis therapy. Eur J Cancer. 2010;46:1323–32.
4. Gardlik R, Celec P, Bernadic M. Targeting angiogenesis for cancer (gene) therapy. Bratisl Lek Listy. 2011;112:428–34.
5. Tammela T, Enholm B, Alitalo K, Paavonen K. The biology of vascular endothelial growth factors. Cardiovasc Res. 2005;65:550–63.